NCT02762890View on ClinicalTrials.gov

Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 6, 2016

Primary Completion Date

February 27, 2017

Study Completion Date

February 27, 2017

Conditions
General Anesthesia
Interventions
DRUG

Deep neuromuscular blockade

neuromuscular blockade will be performed using a continuous infusion of rocuronium. Post-tetanic count 1-2 will be maintained during surgery. After the end of surgery, sugammadex of 4 mg/kg will be administered to reverse neuromuscular blockade.

DRUG

Moderate neuromuscular blockade

neuromuscular blockade will be performed using a continuous infusion of rocuronium. Train-of-four 1-2 will be maintained during surgery. After the end of surgery, sugammadex of 2 mg/kg will be administered to reverse neuromuscular blockade.

Trial Locations (1)

120-752

Department of Anesthesiology and Pain Medicine Anesthesia and Pain Research Institute Yonsei University, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02762890 - Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy | Biotech Hunter | Biotech Hunter